Drug Of Abuse Testing Services Market: Opioids Drug Type Segment Held A Significant Revenue Share

 Drug Of Abuse Testing Services Industry Overview

The global drug of abuse testing services market size was valued at USD 2.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2021 to 2028. An increase in the consumption of alcohol and illicit drugs has led to the high growth of the market. The rise in government initiatives to monitor and combat substance abuse is also significantly driving the market. According to the United Nations Office on Drugs and Crime (UNODC) 2019 data, around 35 million people with substance use disorders were in need of treatment globally. Around 55% of the substance use disorders are associated with opioids and 25% with marijuana. In 2017, 188 million past-year cannabis users were estimated across the world, as per the UNODC data. On the basis of the National Center for Drug Abuse Statistics (NCDAS), around 1.5% to 5% of diseases are direct consequences of using illegal drugs or alcohol addiction.

Access and availability of services are limited for people with substance use disorders globally, with only 1 in 7 cases being treated annually. However, in developed countries such as the U.S., a favorable reimbursement framework for treatment services has led to high demand for substance abuse treatments. With effect from January 1, 2020, the Centers for Medicare & Medicaid Services (CMS) expanded its Medicare coverage to incorporate Medication-assisted Treatment (MAT) in opioid treatment programs.


Gather more insights about the market drivers, restrains and growth of the Global Drug Of Abuse Testing Services market

Various government initiatives to monitor and combat substance abuse are driving the market. The National Drug Control Budget requested USD 34.6 billion in FY 2020 across five drug control functional areas in the U.S.: prevention, operation, treatment, law enforcement, and interdiction. This includes funding of USD 1.9 billion for the Substance Abuse and Mental Health Services Administration (SAMHSA) for the Substance Abuse Prevention and Treatment Block Grant, to fund evidence-based prevention activities. The Department of Defense requested USD 1.2 billion for monitoring and supporting drug interdiction operations as well as other counterdrug operations in the country and other countries.

On the basis of the Federal Drug-free Workplace Program, by Executive Order 12564, a condition has been imposed on all Federal employees to avoid illicit substance use when on the job. This program also facilitates certification of agency drug-free workplace plans and identifies potential areas for initiating random toxicology testing. The SAMHSA Center for Substance Abuse Prevention also supervises HHS-certified laboratories that are working under the program’s mandatory guidelines. The adoption of such drug-testing programs has been mandated among employees working in certain sensitive positions, including public health and safety, law enforcement, and national security. All toxicology testing by public and private entities is conducted according to legal authority or law. Such legal authorities have the power to mandate toxicology testing as well as define conditions under which testing should be done. However, there are limitations that are decided through court cases.

Drug and alcohol abuse among employees is risky for every business. In order to eliminate such risks, employers conduct drug of abuse testing programs; however, this can be considered a violation of privacy rights. In many countries, drug testing is subject to privacy legislation. There are various criteria or standards, based on which such tests can be conducted, and violating them is considered a violation of an individual’s rights.


Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

  • Newborn Screening Market - The global newborn screening market size was valued at USD 783.5 million in 2016 and is expected to grow at a CAGR of 10.6% during the forecast period. Growing neonatal population base, rising cases of congenital diseases in newborns, favorable government programs & legislations, and technological advancements are anticipated to serve as vital drivers of the newborn screening market.

  • Hematologic Malignancies Market - The global hematologic malignancies market size was valued at USD 35.6 billion in the year 2016 with a CAGR of 10.48%. Growing incidence of blood cancer and increasing focus on the development of new treatments are expected to drive the market. Globally, blood malignancies are the fifth most common cancer and is the second most leading cause of cancer deaths.

 

Drug Of Abuse Testing Services Market Segmentation

Grand View Research has segmented the global drug of abuse testing services market on the basis of drug type and region:

Drug Of Abuse Testing Services Drug Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others

 

Drug Of Abuse Testing Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • September 2019: Psychemedics Corporation entered into a new distribution agreement with Toxicologia Pardini Ltda. and Sansão Holding S.A. in Brazil. As per the new contract, Toxicologia Pardini and Sansão were designated as a distributor of Psychemedics’ hair drug testing services in Brazil.

 

Key Companies profiled:

Some prominent players in the global Drug Of Abuse Testing Services market include

  • Quest Diagnostics
  • Abbott Laboratories
  • Clinical Reference Laboratory (CRL), Inc.
  • Laboratory Corporation of America Holdings
  • Cordant Health Solutions
  • Legacy Medical Services
  • DrugScan
  • Omega Laboratories, Inc.
  • Psychemedics Corporation
  • Millennium Health
  • Mayo Clinic Laboratories
  • Precision Diagnostics
  • American Substance Abuse Professionals (ASAP), Inc.
  • United States Drug Testing Laboratories (USDTL), Inc.
  • LGC Group

 

Order a free sample PDF of the Drug Of Abuse Testing Services Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Dna-Based Skin Care Products Market: Offline Distribution Channel Led And Held A Revenue Share

  DNA-based Skin Care Products Industry Overview The global  DNA-based skin care products market  size is expected to reach USD 9.87 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. Consumer awareness of the dangers of using skincare products containing synthetic chemicals is pushing the demand for natural and organic products. Many DNA-based companies have been promoting awareness of DNA-based skincare products through digital and social media campaigns because today's consumers are tech-savvy and want products that are best suited to them.   Everyone's skin is different, so instead of a generic approach from over-the-counter items, consumers need a regimen that is tailored to their own needs. Consumers are now being targeted more directly by skincare specialists, who are prescribing a customized range of products. The Skin360 Face Scanner app from Neutrogena identifies over two...
Read more

Circulating Tumor Cells Market Players: BIOCEPT, Inc., Biocep Ltd., Ikonisys Inc., And Miltenyi Biotec

  Circulating Tumor Cells Industry Overview The global  circulating tumor cells market  size is expected to reach USD 18.3 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.7% from 2021 to 2027. Many potential applications of CTCs in pre-diagnosis, pretreatment, and intra- and post-treatment provide lucrative growth opportunities to players involved in the development of CTC enrichment and isolation products Research organizations are engaged in endeavors aimed at developing CTC-based tests to improve cancer diagnosis in terms of efficiency and speed.   Furthermore, the growing demand for minimally invasive diagnostic procedures is anticipated to propel investments by key stakeholders in this area. CTC-based liquid biopsy tests lead to limited trauma and enable rapid recovery owing to their non-invasive nature. Moreover, it enables minimal invasive screening of tumors before opting for complex...
Read more

Flow Cytometry Market: Asia Pacific Is Projected To Exhibit Exponential Growth During The Forecast Period

  Flow Cytometry Industry Overview The global  flow cytometry market  size is expected to reach a value of USD 11.5 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.9% from 2021 to 2027. The high prevalence of chronic diseases, the introduction of technologically advanced flow cytometry solutions, and increasing R&D investments in the pharmaceutical industry are expected to propel market growth over the forecast period.   Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. Also, in January 2019, Beckman Coulter, a subsidiary of Danaher Corporation, expanded its clinical flow cytometry portfolio with the launch of its new ClearLLab 10C System. This newly la...
Read more